Background: This study aimed to determine the differences in glycemic control, metabolic parameters (blood pressure control, triglycerides, LDL, HDL) and the presence of nephropathy and/or retinopathy between obese and overweight versus normal body mass index (BMI) type 2 diabetes mellitus patients (T2DM).

Methodology: This is an analytic cross-sectional study of T2DM patients from outpatient clinics at St. Luke’s Medical Center, Quezon City. Available medical records and laboratory tests were reviewed. Data were analyzed and compared between those overweight and obese versus those with normal BMI based on Asia Pacific Guidelines.

Results: A total of 248 patients with T2DM were included in the study. More patients who are obese and overweight have uncontrolled diabetes (p = 0.011), low HDL (p = 0.037) and nephropathy (p = 0.027) compared to those with normal BMI. There were no significant difference between overweight and obese patients versus those with normal BMI with regards to BP control, high LDL, high triglycerides and retinopathy.

Conclusion: T2DM patients who are obese and overweight have a significantly higher prevalence of uncontrolled diabetes, low HDL and nephropathy compared to those with normal BMI.

Keywords: Diabetes Mellitus, Obese, Overweight, Nephropathy, Retinopathy

1. World Health Organization. Diabetes. July 2017. Retrieved from http://www.who.int/mediacentre/factsheets/fs312/en/.
2. International Diabetes Federation. Diabetes Atlas 6th edition poster update, 2014. http://www.idf.org/sites/default/files/Atlas-poster- 2014_EN.pdf. Accessed September 22, 2016.
3. Ramachandran A, Snehalatha C, Ma RC. Diabetes in South-East Asia: an update. Diabetes Res Clin Pract. 2014;103(2):231-7. PMID: 24300015. https://doi.org/10.1016/j.diabres.20111.011.
4. World Health Organization. Obesity. Retrieved from http://www.who.int/topics/obesity/en/.
5. Dulloo, AG, Solinas, J, Montani, Jp, and Schutz, Y. Body Composition Phenotypes in Pathways to Obesity and the Metabolic Syndrome. International Journal of Obesity (2010) 34 S4-S17.
6. Phillips LK, Prins JB: The link between abdominal obesity and the metabolic syndrome. Curr Hypertens Rep 2008; 10(2): 156–64.
7. Doehner W, Erdmann E, Cairns R, et al. Inverse relation of body weight and weight change with mortality and morbidity in patients with type 2 diabetes and cardiovascular co-morbidity: an analysis of the PROactive study population. Int J Cardiol 2012; 162:20–26
8. Hainer, V., & Aldhoon-Hainerová, I. (2013). Obesity Paradox Does Exist. Diabetes Care, 36(Suppl 2), S276–S281. http://doi.org/10.2337/dcS13-2023
9. Heymsfield SB, Cefalu WT. Does body mass index adequately convey a patient’s mortality risk? JAMA 2013; 309:87–88
10. Lumi, E. et al. The Relationship of Body Mass Index to Diabetes Mellitus and Prediabetes. International Journal of Life Sciences Research. Vol. 4, Issue 1, pp: (144-147), Month: January - March 2016.
11. Dangi, R., and Gaur, V.B. Effect of Body Mass Index on Microvascular Complications of Type Ii Diabetes Mellitus. International Journal of Current Research in Life Sciences. Vol 3, No. 12, pp 97-100, December 2014.
12. Hubert, H. et al. Obesity as an Independent Risk Factor for Cardiovascular Disease: A 26-year Follow-up of Participants in the Framingham Heart Study. Circulation. 1983.
13. Chagnac A, Weinstein T, Korzets A, et al. Glomerular hemodynamics in severe obesity. Am J Physiol Ren Physiol. 2000;278:F817– 22.
14. Bautista, F. P., Jasul Jr., G., & Dampil, O. A. (2019). Insulin Resistance and β-Cell Function of Lean versus Overweight or Obese Filipino Patients with Newly Diagnosed Type 2 Diabetes Mellitus. JAFES, 34(2), 164-170. https://doi.org/10.15605/jafes.034.02.07
15. Asegaonkar SB, Karee I, Aghade S, Pagdhune A, Thorat A, Borkar MS. Metabolic status of lean, overweight, and obese type 2 diabetes mellitus patients. Indian J Med Biochem. 2016; 20(1): 6-10. https://doi. org/10.5005/jp-journals-10054-0002.
16. Akter R, Nessa A, Husain MF, et al. Effect of obesity on fasting blood sugar. Mymensingh Med J. 2017; 26(1):7-11. PMID: 28260748.
17. Al-Goblan AS, Al-Alfi MA, Khan MZ. Mechanism linking diabetes mellitus and obesity. Diabetes Metab Syndr Obes. 2014; 7:587-91. PMID: 25506234. PMCID: PMC4259868. https://doi.org/10.2147/DMSO.S67400.
18. Lukich, A., Gavish, D. & Shargorodsky, M. Normal weight diabetic patients versus obese diabetics: relation of overall and abdominal adiposity to vascular health. Cardiovasc Diabetol 13, 141 (2014). https://doi.org/10.1186/s12933-014-0141-8
19. Silva-Nunes, José & Brito, Miguel & Veiga, Luisa. (2020). Blood pressure and its circadian pattern in obese and lean premenopausal women. Arterial Hypertension (Poland). 24. 30-37. 10.5603/AH. a2020.0005.
20. Hussain, A., Ali, I., Kaleem, W. A., & Yasmeen, F. (2019). Correlation between Body Mass Index and Lipid Profile in patients with Type 2 Diabetes attending a tertiary care hospital in Peshawar. Pakistan journal of medical sciences, 35(3), 591–597. https://doi.org/10.12669/pjms.35.3.7
21. Bansal, P., Upadhyay, H. P., & Jha, R. (2018). Correlation between Body Mass Index and Lipid Profile in a Diabetic population of Central Nepal. Journal of College of Medical Sciences-Nepal, 14(4), 184–188. https://doi.org/10.3126/jcmsn.v14i4.21997
22. Augusthy A, Sahu S, Kumar Jeppu A, Jawalekar S, Marakala V, Maria Thomas Thattil A. A comparison of BMI and Lipid Profile in patients with metabolic syndrome and Type 2 Diabetes Mellitus. Int J Med Res Rev [Internet]. 2017Mar.31 [cited 2022Jun.2];5(3):357-62. Available from: https://ijmrr.medresearch.in/index.php/ijmrr/article/view/847
23. Ou, Y. L., Lee, M. Y., Lin, I. T., Wen, W. L., Hsu, W. H., & Chen, S. C. (2021). Obesity-related indices are associated with albuminuria and advanced kidney disease in type 2 diabetes mellitus. Renal failure, 43(1), 1250–1258. https://doi.org/10.1080/0886022X.2021.1969247
24. Kawar B, Bello AK, El Nahas AM.. High prevalence of microalbuminuria in the overweight and obese population: data from a UK population screening programme. Nephron Clin Pract. 2009;112(3):c205–c212.
25. Zhou, Y., Zhang, Y., Shi, K., & Wang, C. (2017). Body mass index and risk of diabetic retinopathy: A meta-analysis and systematic review. Medicine, 96(22), e6754. https://doi.org/10.1097/MD.0000000000006754
26. Zhu, Wei MD, Wu, Yan MD, Meng, Yi-Fang MD, Xing, Qian MD, Tao, Jian-Jun MD, Lu, Jiong MD. (2018). Association of obesity and risk of diabetic retinopathy in diabetes patients. Medicine. Volume 97 - Issue 32 - p e11807 doi: 10.1097/MD.0000000000011807
27. Ahren J, Ahren B, Wierup N. Increased beta-cell volume in mice fed a high-fat diet: a dynamic study over 12 months. Islets 2010; 2:353–6.
28. Cai X, Han X, Zhang S, et al. Age at diagnosis and C-peptide level are associated with diabetic retinopathy in Chinese. PLoS One 2014;9:e91174.
29. Yau JW, Rogers SL, Kawasaki R, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care2012; 35:556–64.
30. Considine RV, Sinha MK, Heiman ML, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996; 334:292–5